{
    "id": "correct_subsidiary_00047_0",
    "rank": 35,
    "data": {
        "url": "https://adisinsight.springer.com/drugs/800012483",
        "read_more_link": "",
        "language": "en",
        "title": "Betamethasone valerate foam",
        "top_image": "https://storage.googleapis.com/pcf_sb_39_1613727931605803249/assets/images/ajax_loader.gif",
        "meta_img": "",
        "images": [
            "https://storage.googleapis.com/pcf_sb_39_1613727931605803249/assets/images/ajax_loader.gif",
            "https://adisinsight.springer.com/assets/images/adisinsight_logo.svg",
            "https://storage.googleapis.com/pcf_sb_39_1613727931605803249/assets/images/loading_search.gif",
            "https://adisinsight.springer.com/static/private/chemicalimage/thumb/3/800012483.png",
            "https://adisinsight.springer.com/static/private/chemicalimage/png/3/800012483.png",
            "https://adisinsight.springer.com/assets/images/icons/springer.svg",
            "https://adisinsight.springer.com/assets/images/icons/springernature.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Betamethasone valerate foam - Stiefel Laboratories",
            "0.12 betamethasone 17alfavalerate",
            "0.12 betamethasone 17alphavalerate",
            "0.12 betamethasone 17avalerate",
            "0.12 betamethasone 17valerate",
            "0.12 betamethasone valerate Stiefel",
            "Betamousse",
            "Luxiq",
            "Steroid receptor agonists",
            "Anti-inflammatories",
            "Antiallergics",
            "Antiasthmatics",
            "Antipsoriatics",
            "Fluorinated steroids",
            "Glucocorticoids",
            "Small molecules",
            "Soltec Research",
            "Stiefel Laboratories",
            "Mipharm",
            "Psoriasis",
            "Atopic dermatitis"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Connetics (now Stiefel Laboratories) has developed a stabilised foam formulation of 0.12% betamethasone valerate, a mid-potency corticosteroid, after acquiring",
        "meta_lang": "en",
        "meta_favicon": "https://storage.googleapis.com/pcf_sb_39_1613727931605803249/assets/images/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "http://adisinsight.springer.com",
        "text": "Subscriber content\n\nYou need to be a logged in subscriber to view this content.\n\nIf your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.\n\nIP authentication when working within your organization’s network.\n\nLogin with username/password or try access via your institution\n\nPersisted access using your organization’s identifier stored in your user browser for 90 days.\n\nContact us at AsktheExpert.AdisInsight@springer.com for assistance.\n\nIf your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following."
    }
}